Virtus ETF Advisers LLC Sorrento Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $37,721 - $93,284	50,975 Added 68.8%	125,062 $111,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $815 - $1,555	540 Added 0.73%	74,087 $116,000
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $59,668 - $112,119	48,120 Added 189.25%	73,547 $148,000
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $3,002 - $7,354	-1,501 Reduced 5.57%	25,427 $59,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $20,752 - $32,267	4,463 Added 19.87%	26,928 $125,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $8,751 - $12,979	-1,181 Reduced 4.99%	22,465 $171,000
Q2 2021 Aug 10, 2021	SELL	$6.35 - $10.0 $104,482 - $164,540	-16,454 Reduced 41.03%	23,646 $229,000
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $5,012 - $11,771	713 Added 1.81%	40,100 $332,000
Q4 2020 Feb 12, 2021	SELL	$5.76 - $11.95 $158,192 - $328,194	-27,464 Reduced 41.08%	39,387 $269,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $56,350 - $171,883	-9,133 Reduced 12.02%	66,851 $745,000
Q2 2020 Aug 05, 2020	SELL	$1.73 - $6.76 $21,379 - $83,540	-12,358 Reduced 13.99%	75,984 $477,000
Q1 2020 May 14, 2020	SELL	$1.57 - $4.76 $20,212 - $61,280	-12,874 Reduced 12.72%	88,342 $163,000
Q4 2019 Feb 13, 2020	BUY	$1.45 - $4.17 $30,452 - $87,578	21,002 Added 26.18%	101,216 $342,000
Q3 2019 Nov 12, 2019	SELL	$2.05 - $2.69 $9,159 - $12,018	-4,468 Reduced 5.28%	80,214 $172,000
Q2 2019 Aug 13, 2019	SELL	$2.67 - $4.38 $61,620 - $101,086	-23,079 Reduced 21.42%	84,682 $226,000
Q1 2019 May 14, 2019	SELL	$1.86 - $5.94 $29,875 - $95,408	-16,062 Reduced 12.97%	107,761 $512,000
Q4 2018 Feb 05, 2019	BUY	$2.01 - $4.24 $122,875 - $259,199	61,132 Added 97.51%	123,823 $297,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $194,225 - $345,187	-46,025 Reduced 42.34%	62,691 $276,000
Q2 2018 Aug 10, 2018	BUY	$4.75 - $8.0 $516,401 - $869,728	108,716 New	108,716 $783,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account